JIC
TEVA icon

Johnson Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Johnson Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,914
Closed -$381K – 595
2020
Q2 		$381K Buy
30,914
+1,222
+4% +$13.8K 0.01% 431
2020
Q1 		$267K Sell
29,692
-519
-2% -$5.32K 0.01% 473
2019
Q4 		$296K Sell
30,211
-11,996
-28% -$107K 0.01% 509
2019
Q3 		$290K Buy
+42,207
New +$323K 0.01% 507
2019
Q2 		– Sell
-12,056
Closed -$189K – 624
2019
Q1 		$189K Sell
12,056
-13
-0.1% -$229 ﹤0.01% 577
2018
Q4 		$186K Sell
12,069
-545
-4% -$11.2K ﹤0.01% 575
2018
Q3 		$271K Buy
12,614
+150
+1% +$3.48K 0.01% 538
2018
Q2 		$303K Sell
12,464
-46
-0.4% -$938 0.01% 519
2018
Q1 		$213K Sell
12,510
-1,950
-13% -$38.1K 0.01% 576
2017
Q4 		$274K Buy
14,460
+158
+1% +$2.38K 0.01% 534
2017
Q3 		$251K Sell
14,302
-2,994
-17% -$67.4K 0.01% 543
2017
Q2 		$574K Sell
17,296
-551
-3% -$17.1K 0.02% 375
2017
Q1 		$572K Buy
17,847
+2,907
+19% +$99.2K 0.02% 358
2016
Q4 		$541K Buy
14,940
+4,119
+38% +$164K 0.02% 351
2016
Q3 		$497K Sell
10,821
-266
-2% -$13.9K 0.02% 346
2016
Q2 		$556K Buy
11,087
+441
+4% +$23.5K 0.02% 321
2016
Q1 		$569K Sell
10,646
-917
-8% -$53.8K 0.02% 310
2015
Q4 		$758K Sell
11,563
-676
-6% -$41.8K 0.03% 256
2015
Q3 		$691K Sell
12,239
-2,457
-17% -$159K 0.03% 262
2015
Q2 		$868K Sell
14,696
-360
-2% -$22.2K 0.03% 233
2015
Q1 		$937K Sell
15,056
-339
-2% -$19.7K 0.03% 228
2014
Q4 		$885K Sell
15,395
-7,425
-33% -$414K 0.03% 234
2014
Q3 		$1.23M Buy
22,820
+2,656
+13% +$141K 0.04% 192
2014
Q2 		$1.06M Buy
20,164
+1,542
+8% +$78.8K 0.04% 188
2014
Q1 		$983K Sell
18,622
-692
-4% -$32K 0.04% 194
2013
Q4 		$774K Buy
19,314
+26
+0.1% +$1.02K 0.03% 222
2013
Q3 		$728K Sell
19,288
-3,812
-17% -$149K 0.03% 212
2013
Q2 		$905K Buy
+23,100
New +$900K 0.04% 178

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Johnson Investment Counsel's TEVA Position: Q3 2020 in Review

Johnson Investment Counsel sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 30,914 shares — an estimated $381K sold.

Johnson Investment Counsel first reported a position in TEVA in Q2 2013 and held it in 28 quarters. The position peaked at $1.23M in Q3 2014. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Johnson Investment Counsel reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Johnson Investment Counsel sold 30,914 Teva Pharmaceuticals shares in Q3 2020, an estimated $381K.
  • Johnson Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Johnson Investment Counsel's Teva Pharmaceuticals position peaked at $1.23M in Q3 2014.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Johnson Investment Counsel's 13F filing for Q3 2020, filed 16 Nov 2020.